| Literature DB >> 29740288 |
Sarah E Motley1,2.
Abstract
Entities:
Keywords: acetylcholine; dlPFC; dopamine; neuromodulation; norepinephrine; serotonin; working memory
Mesh:
Substances:
Year: 2018 PMID: 29740288 PMCID: PMC5928252 DOI: 10.3389/fncir.2018.00031
Source DB: PubMed Journal: Front Neural Circuits ISSN: 1662-5110 Impact factor: 3.492
Effects of neurotransmitter and neuromodulator modulation during a Delayed Response task on cell type-specific firing in the dlPFC and behavioral performance.
| Glutamate GluN2A subunit | Antagonist | ? | ? | ? | ? | ? | Wang et al., | |
| Glutamate GluN2B subunit | Antagonist | ? | ? | Wang et al., | ||||
| Glutamate NMDAR | Antagonist | ? | Local: | ? | ? | Impaired | Wang et al., | |
| Glutamate NMDAR | Agonist | ? | ? | ? | ? | ? | Wang et al., | |
| Glutamate AMPAR | Antagonist | No effect | Perisaccadic: no effect; | ? | ? | Wang et al., | ||
| Acetylcholine muscarinic receptor | Antagonist | ? | ? | ? | ? | ? | Impaired | Bartus and Johnson, |
| Acetylcholine nicotinic receptor | Antagonist | ? | ? | Yang et al., | ||||
| Acetylcholine α4β2R | Antagonist | ? | No effect | ? | ? | ? | Sun et al., | |
| “ | Agonist | No effect | No effect | No effect | ? | Sun et al., | ||
| Acetylcholine α7R | Antagonist | No effect | No effect | ? | ? | ? | Yang et al., | |
| “ | Agonist | ? | Low dose: | Low dose: No effect | ? | ? | Low dose: enhanced | Yang et al., |
| Dopamine D1R | Antagonist | No effect | Low dose: | Low dose: No effect | No effect | ? | Impaired | Sawaguchi and Goldman-Rakic, |
| “ | Agonist | ? | Low dose: No effect | Low dose: | ? | ? | Enhanced | Arnsten et al., |
| Dopamine D2R | Antagonist | No effect | No effect | No effect | ? | ? | Wang et al., | |
| “ | Agonist | No effect | No effect | No effect | ? | Low dose: impaired | Arnsten et al., | |
| Norepinephrine α1-AR | Antagonist | ? | ? | ? | ? | ? | No effect | Li and Mei, |
| “ | Agonist | ? | ? | ? | ? | Impaired | Arnsten and Jentsch, | |
| Norepinephrine α2-AR | Antagonist | ? | ? | ? | ? | Impaired | Arnsten and Goldman-Rakic, | |
| “ | Agonist | ? | ? | ? | ? | Low dose: no effect | Arnsten and Goldman-Rakic, | |
| Norepinephrine general β-AR | Antagonist | ? | ? | ? | ? | ? | No effect | Arnsten and Goldman-Rakic, |
| Norepinephrine β1-AR | Antagonist | ? | ? | ? | ? | ? | Enhanced | Ramos et al., |
| Norepinephrine β2-AR | Agonist | ? | ? | ? | ? | ? | Enhanced | Arnsten and Goldman-Rakic, |
| Serotonin 5-HT2AR | Antagonist | ? | ? | ? | ? | ? | Williams et al., | |
| “ | Agonist | ? | ? | ? | ? | Williams et al., | ||
| Serotonergic receptor | Agonist | ? | Low dose: | Low dose: | ? | ? | ? | Williams et al., |